These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 852110)

  • 1. Interference by p-hydroxyphenobarbital in the 125I-radioimmunoassay of serum and urinary phenobarbital.
    Viswanathan CT; Booker HE; Welling PG
    Clin Chem; 1977 May; 23(5):873-6. PubMed ID: 852110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous determination of phenobarbital and p-hydroxyphenobarbital and their stable isotope labeled analogs by gas chromatography mass spectrometry.
    Van Langenhove A; Biller JE; Biemann K; Browne TR
    Biomed Mass Spectrom; 1982 May; 9(5):201-7. PubMed ID: 7093441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GC and GC-mass spectrometric determination of p-hydroxyphenobarbital extracted from plasma, urine, and hepatic microsomes.
    Kapetanović IM; Kupferberg HJ
    J Pharm Sci; 1981 Nov; 70(11):1218-24. PubMed ID: 7299667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous analysis of phenobarbital and p-hydroxyphenobarbital in biological fluids by GLC-chemical-ionization mass spectrometry.
    Patel IH; Levy RH; Neal JM; Trager WF
    J Pharm Sci; 1980 Oct; 69(10):1218-9. PubMed ID: 7420295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of phenobarbital, p-hydroxyphenobarbital and phenobarbital-N-glucoside in urine by gas chromatography chemical ionization mass spectrometry.
    Tang BK; Yilmaz B; Kalow W
    Biomed Mass Spectrom; 1984 Sep; 11(9):462-5. PubMed ID: 6509155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenobarbital disposition in the neonate.
    Garrettson LK
    Addict Dis; 1975; 2(1-2):179-85. PubMed ID: 1163361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microassay for primidone and its metabolites phenylethylmalondiamide, phenobarbital and p-hydroxyphenobarbital in human serum, saliva, breast milk and tissues by gas chromatography--mass spectrometry using selected ion monitoring.
    Nau H; Jesdinsky D; Wittfoht W
    J Chromatogr; 1980 Apr; 182(1):71-9. PubMed ID: 7380904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of dose-plasma concentration relationship of phenobarbital in epileptic patients by a new specific radioimmunoassay.
    Kawashima K; Ishijima B; Yoshimizu N; Sato F
    Arch Int Pharmacodyn Ther; 1980 Mar; 244(1):166-76. PubMed ID: 7416885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-performance liquid chromatographic analysis of phenobarbital and phenobarbital metabolites in human urine.
    Paibir SG; Soine WH
    J Chromatogr B Biomed Sci Appl; 1997 Mar; 691(1):111-7. PubMed ID: 9140764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid quantitative determination of underivatized carbamazepine, phenytoin, phenobarbital and p-hydroxyphenobarbital in biological fluids by packed column gas chromatography.
    Riva R; Albani F; Baruzzi A
    J Chromatogr; 1980 Nov; 221(1):75-84. PubMed ID: 7451626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sample stacking microemulsion electrokinetic capillary chromatography induced by reverse migrating pseudostationary phase for the quantification of phenobarbital and its p-hydroxyphenobarbital metabolite in rat urine.
    Kadi A; Hefnawy M; Julkhuf S; Abounassif M; Mostafa G; Kassem MG; Attia S; Al-Ghamdi A
    Analyst; 2011 Jul; 136(13):2858-65. PubMed ID: 21607283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of phenobarbital and its main metabolites in human urine.
    Kallberg N; Agurell S; Ericsson O; Bucht E; Jalling B; Boréus LO
    Eur J Clin Pharmacol; 1975 Dec; 9(2-3):161-8. PubMed ID: 1233264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic fate of phenobarbital in man. N-Glucoside formation.
    Tang BK; Kalow W; Grey AA
    Drug Metab Dispos; 1979; 7(5):315-8. PubMed ID: 40773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LC determination of the diastereomers of 1-(beta-D-glucopyranosyl)phenobarbital in human urine.
    Soine WH; Soine PJ; England TM; Welty DF; Wood JH
    J Pharm Biomed Anal; 1990; 8(4):365-72. PubMed ID: 2100211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of liver disease in man on the disposition of phenobarbital.
    Alvin J; McHorse T; Hoyumpa A; Bush MT; Schenker S
    J Pharmacol Exp Ther; 1975 Jan; 192(1):224-35. PubMed ID: 235636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of phenobarbital and p-hydroxyphenobarbital by densitometry of thin layers.
    Levin SS; Schwartz MF; Cooper DY; Touchstone JC
    J Chromatogr; 1978 Jul; 154(2):349-52. PubMed ID: 681484
    [No Abstract]   [Full Text] [Related]  

  • 17. A quantitative barbiturate determination in urine and serum.
    de Bruijn D
    Clin Chim Acta; 1974 Jun; 53(3):385-8. PubMed ID: 4847114
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of diphenylhydantoin and its main hydroxylated metabolite on the pharmacokinetics and the urinary and biliary excretion of phenobarbital and its p-hydroxy metabolite.
    Sarhan F; Engasser JM; Batt AM; Magdalou J; Siest G
    Eur J Drug Metab Pharmacokinet; 1981; 6(2):99-108. PubMed ID: 7306277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of phenobarbital glucosidation in the human neonate.
    Bhargava VO; Garrettson LK
    Dev Pharmacol Ther; 1988; 11(1):8-13. PubMed ID: 3383723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of phenobarbital following single and repeated doses.
    Viswanathan CT; Booker HE; Welling PG
    J Clin Pharmacol; 1979; 19(5-6):282-9. PubMed ID: 469023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.